Screener
Rapport Therapeutics, Inc. RAPP Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from Rapport Therapeutics, Inc.’s reported figures.
Based on trailing twelve months.
The source filing: Rapport Therapeutics, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 7:30 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333862
FAQ
- What is Rapport Therapeutics, Inc.'s return on equity?
- Rapport Therapeutics, Inc. (RAPP) reported return on equity of -40% in Q2 2026.
- How has Rapport Therapeutics, Inc.'s return on equity changed year-over-year?
- Rapport Therapeutics, Inc.'s return on equity decreased by 35.8% year-over-year, from -29.4% to -40%.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.
Ask your AI about Rapport Therapeutics, Inc.'s return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude